| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $110.16 | $24.19 | 355.40% | 207.85x | 52.43x | 13.97x | 16.87x | 1.51x | $106.92M | 0.92% | $705.78M | 6.70 | $11.81B | 1,504.97 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $28.82 | $8.29 | 247.51% | 137.24x | 65.43x | 8.11x | 16.42x | 1.17x | $39.15M | 1.04% | $220.58M | 1.69 | $3.70B | 81.56 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $231.83 | $83.50 | 177.65% | 38.00x | 34.91x | 6.45x | 22.91x | 1.25x | $793.95M | 2.56% | $1.35B | 10.14 | $32.30B | 27.39 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $78.59 | $17.45 | 350.29% | 73.45x | 67.23x | 7.25x | 9.37x | 1.87x | $182.84M | 3.00% | $654.15M | 8.43 | $5.97B | 49.73 | ||
| KRYS | KRYSTAL BIOTECH INC | $316.58 | $83.87 | 277.47% | 38.28x | 41.18x | 21.22x | 6.89x | 2.07x | $257.78M | 2.76% | $1.36B | 46.03 | $8.95B | 38.37 | ||
| VCEL | VERICEL CORP | $40.13 | $8.04 | 398.96% | 83.60x | 71.70x | 6.69x | 5.55x | 2.05x | $61.66M | 3.01% | $370.04M | 7.25 | $2.02B | 45.91 | ||
| RPRX | ROYALTY PHARMA PLC | $60.96 | $36.51 | 66.95% | 32.43x | 11.22x | 10.70x | 3.58x | 0.65x | $2.92B | 10.78% | $9.79B | 21.99 | $43.20B | 36.73 | ||
| HALO | HALOZYME THERAPEUTICS INC | $121.84 | $72.04 | 69.13% | 34.22x | 13.46x | 8.59x | 96.34x | 0.65x | $806.22M | 5.64% | $143.54M | 1.22 | $15.81B | 22.01 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $54.68 | $18.91 | 189.23% | 143.89x | 19.83x | 3.10x | 1.67x | 0.95x | $738.18M | 6.98% | $6.32B | 32.68 | $13.90B | 36.03 | ||
| TGTX | TG THERAPEUTICS INC | $53.97 | $23.18 | 132.79% | 17.52x | 53.84x | 9.57x | 13.68x | 1.81x | $17.39M | 0.23% | $604.08M | 4.26 | $8.53B | 61.27 | ||
| ADMA | ADMA BIOLOGICS INC | $10.68 | $7.02 | 52.15% | 14.83x | 13.42x | 4.76x | 5.86x | 0.86x | $116.47M | 4.78% | $408.21M | 1.79 | $2.45B | 10.53 | ||
| MDXG | MIMEDX GROUP INC | $4.43 | $1.21 | 265.08% | 110.75x | -24.58x | 1.84x | 2.99x | 1.28x | $44.50M | 6.79% | $216.00M | 1.46 | $527.09M | 23.11 | ||
| EXEL | EXELIXIS INC | $62.23 | $30.80 | 102.06% | 18.91x | 18.69x | 6.41x | 8.36x | 1.19x | $1.17B | 7.51% | $1.84B | 7.35 | $15.30B | 14.07 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $9.94 | $7.66 | 29.82% | 10.46x | 9.14x | 4.32x | 2.71x | 0.91x | $82.01M | 13.94% | $217.65M | 3.68 | $446.45M | 5.77 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $210.23 | $182.32 | 15.31% | 13.78x | 8.80x | 2.89x | 2.84x | 0.56x | $1.62B | 12.19% | $4.80B | 75.98 | $16.42B | 10.16 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $295.54 | $86.87 | 240.21% | 29.35x | 31.30x | 20.41x | 6.09x | 2.19x | $130.62M | 2.20% | $967.52M | 48.22 | $6.02B | 21.57 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $499.74 | $149.17 | 235.02% | 28.84x | 26.16x | 10.07x | 6.26x | 2.17x | $3.80B | 2.99% | $20.25B | 79.81 | $122.50B | 22.26 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $37.95 | $31.03 | 22.29% | 12.09x | 9.10x | 2.29x | 2.21x | 0.69x | $354.90M | 16.14% | $999.24M | 17.25 | $1.81B | 6.48 | ||
| UTHR | UNITED THERAPEUTICS CORP | $533.12 | $189.63 | 181.14% | 17.63x | 19.72x | 7.20x | 3.57x | 3.24x | $1.09B | 4.81% | $6.40B | 150.24 | $21.06B | 12.56 | ||
| TECH | BIO-TECHNE CORP | $72.57 | $16.41 | 342.23% | 62.03x | 34.93x | 9.31x | 5.40x | 1.97x | $263.22M | 2.33% | $2.11B | 13.52 | $11.40B | 32.80 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $790.74 | $432.05 | 83.02% | 18.85x | 13.53x | 5.23x | 2.57x | 0.99x | $3.76B | 4.63% | $31.71B | 308.48 | $81.66B | 14.20 | ||
| VCYT | VERACYTE INC | $43.12 | $11.99 | 259.73% | 29.94x | 22.18x | 6.14x | 2.50x | 2.42x | $165.99M | 4.81% | $1.39B | 17.36 | $3.21B | 22.95 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.10 | $1.40 | -21.23% | 7.86x | -2.48x | 1.36x | 1.45x | 0.44x | $19.58M | 30.73% | $44.20M | 0.76 | $15.33M | 2.01 | ||
| INCY | INCYTE CORP | $113.07 | $57.97 | 95.06% | 13.92x | 33.63x | 3.89x | 3.61x | 1.67x | $1.92B | 8.48% | $6.34B | 31.66 | $18.97B | 9.17 |